Synergo RITE
Asset
Radiofrequency-induced bladder hyperthermia enhances the local effects of intravesical chemotherapy.
- Stage
- Phase 3
- Modality
- Device
- Target
- Not known
- 10
- Indications
- 162
- Trials
- 1
- Developer
Indications
10Bcg unresponsive bladder cancer
Phase 3, Terminated, NCT03335059, clinicaltrials.gov, 17 Oct 2026
Bladder cancer
Phase 3, Terminated, NCT03335059, clinicaltrials.gov, 17 Oct 2026
Bladder neoplasm
Phase 3, Terminated, NCT03335059, clinicaltrials.gov, 17 Oct 2026
7 more
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials162
- Evidence for its targets1
- Competitors1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.